Glycine-Arginine Elution Buffer for Downstream Chromatography
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing protein purification methods face challenges in maintaining high yield and activity while ensuring compatibility with downstream processing, particularly due to ion exchange effects and pH instability during acidic elution in affinity chromatography, leading to protein denaturation and aggregation.
Innovation Solution
The use of an elution buffer comprising glycine and arginine, tailored to specific conductivity and pH levels, minimizes ion exchange effects and stabilizes the protein, allowing compatibility with subsequent chromatographic steps.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If acidic elution buffer is used in affinity chromatography, then elution efficiency is improved, but protein stability deteriorates leading to denaturation and aggregation
Solution Approach 1:
The patent changes the chemical composition parameters of the elution buffer by incorporating amino acids (arginine, glycine, histidine, lysine, or ornithine) at specific concentrations (0.1-1.0 M) alongside acidic pH conditions. This parameter modification allows the buffer to maintain low pH for effective elution while the amino acids provide stabilizing interactions with the protein surface, preventing denaturation and aggregation that would otherwise occur under acidic conditions.
2Reliability
If salt concentration is increased to raise elution pH, then protein stability is improved, but conductivity increases limiting downstream chromatography choices
Solution Approach 1:
The patent changes the pH control mechanism from salt-dependent to amino acid-dependent. By using amino acids as pH-modifying agents rather than high concentrations of salt, the buffer achieves higher pH values (reducing acidity stress on proteins) without proportionally increasing conductivity. The amino acids provide buffering capacity and protein stabilization through specific molecular interactions, allowing downstream chromatography steps to proceed without extensive dilution.
3Reliability
If organic solvents are added to increase elution pH, then protein stability is improved, but protein denaturation occurs and viscosity increases creating safety issues
Solution Approach 1:
The patent replaces organic solvent additives with amino acid-based buffering systems. The amino acids (arginine, glycine, histidine, lysine, or ornithine) achieve pH modulation and protein stabilization through aqueous-phase chemical interactions, including zwitterionic buffering and surface binding, without introducing the denaturing effects, high viscosity, and safety hazards associated with organic solvents.
4Adaptability or versatility
If extensive dilution is performed to reduce conductivity for downstream steps, then downstream chromatography compatibility is improved, but processing time and costs increase
Solution Approach 1:
The patent changes the conductivity profile of the elution buffer by using amino acids instead of high salt concentrations. The amino acid buffers provide sufficient pH control and protein stabilization at lower ionic strengths, resulting in elution pools with conductivity levels that are directly compatible with subsequent chromatographic steps. This eliminates or minimizes the need for time-consuming dilution steps and associated cost increases.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enhances protein stability and yield, maintaining high activity and reducing aggregation, while enabling flexibility in downstream processing without the need for extensive dilution or high salt concentrations.
Implementation Method 1
affinity resins have an ion exchange effect at the start of elution, causing subsequent conductivity and pH changes on the affinity column
Implementation Method 2
amino acids such as arginine and glycine are safe excipients, soluble in aqueous solvents, and increase protein stability by facilitating preferential interaction of solvent components with proteins, and through beneficial effects on surface tension and structure of an aqueous solvent
Data Source
AI summary
The present invention provides, among other things, methods of purifying a protein or polypeptide by affinity chromatography, for example, custom affinity chromatography, followed by downstream chromatographic steps, comprising eluting the recombinant protein from the affinity column using an elution buffer wherein the elution buffer comprises glycine and arginine at a concentration such that conductivity is no greater than the conductivity limit of the subsequent chromatographic resin.